Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-108793
Filing Date
2024-09-23
Accepted
2024-09-23 16:53:56
Documents
67
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A revb-20231231.htm   iXBRL 10-K/A 1331619
2 EX-23.1 revb-ex23_1.htm EX-23.1 5311
3 EX-31.1 revb-ex31_1.htm EX-31.1 26729
4 EX-31.2 revb-ex31_2.htm EX-31.2 26788
5 EX-32.1 revb-ex32_1.htm EX-32.1 10365
6 EX-32.2 revb-ex32_2.htm EX-32.2 11044
  Complete submission text file 0000950170-24-108793.txt   7319993

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT revb-20231231.xsd EX-101.SCH 1448704
70 EXTRACTED XBRL INSTANCE DOCUMENT revb-20231231_htm.xml XML 1013623
Mailing Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122
Business Address 4660 LAJOLLA VILLAGE DRIVE SUITE 100 SAN DIEGO CA 92122 650-800-3717
REVELATION BIOSCIENCES, INC. (Filer) CIK: 0001810560 (see all company filings)

EIN.: 843898466 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39603 | Film No.: 241316752
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)